Top Industry News
- Swissmedic - New Regulatory Law Applies from 1 November 2024
- Malaysia MDA - Implementation of the One License For Each Establishment Role 1 July 2024
- Partial Revision of Food Standards and Specifications - Ministry of Food and Drug Safety Notice No. 2024-22
- ANVISA Changes the Rule that Deals With the Post-Registration of Biological Products
- TGA - Proactive Monitoring of Highest-Risk Medical Device Clinical Trials
- The Scientific Committee on Consumer Safety (SCCS) has Released a Draft Opinion on a New Coating for Titanium Dioxide
- Swissmedic - Adaptation of the Guideline Changes and Authorisation Extensions HAM
- EPA Proposes New Regulations to Safeguard Against Hazardous Chemical N-Methylpyrrolidone (NMP)
- PMDA Updated "Submission of Documents to the Pharmaceutical Affairs Council (Medical Drugs)"
- WTO- Requirements, Sampling and Test Methods for Nixtamalized Maize Products Prepared from the Grains of Common Maize (Zea mays L.) Intended for Human Consumption
- FDA Draft Guidance on Standardized Format for Electronic Submission for Marketing Applications Content for the Planning of Bioresearch Monitoring (BIMO) Inspections for Center for Biologics Evaluation and Research Submissions
- Health Canada's PMRA is Seeking Public Comments on Proposed Maximum Residue Limits (MRLs) for the Pesticide Picarbutrazox by July 30, 2024
- PMDA Published Guidelines for Filling out Electronic Package Inserts for Regenerative Medicine Products
- FDA Draft Guidance on Processes and Practices Applicable to Bioresearch Monitoring Inspections
- Taiwan FDA -Restricted List of Ingredients for Cosmetic Sunscreens
- PMDA Published Guidelines for Promoting Optimal use of Regenerative Medicine Products